UK Markets closed

Cannabis stocks

Cannabis stocks

161.98k followers18 symbols Watchlist by Yahoo Finance

Follow this list to discover and track the stock of publicly traded companies with exposure to cannabis

Curated by Yahoo Finance


Global spending on legal cannabis worldwide will hit over £43 billion in a decade, according to Arcview Market Research and BDS Analytics. Driven by the legalisation of recreational and medical cannabis and the increasing demand for both, legal cannabis revenue in the US is projected to hit £17.8 billion by 2022. Yahoo Finance is now tracking the major players in the cannabis industry.

How do we pick these stocks?

This is a curated list, powered by Yahoo Finance’s algorithm and intelligence from our millions of users as well as the Yahoo Finance editorial team. The list covers companies in horticulture, pharmaceutical research and ancillary businesses. We will continue to add names as corporations invest and pivot into the space.

How are these weighted?

The stocks on this watchlist are weighted equally at the time they were added.

To learn what every company on this list is doing that involves cannabis, read this story.


WatchlistChange today1-month return1-year returnTotal return
Cannabis stocks-0.61%+58.10%-9.72%+327.19%

18 symbols

SymbolCompany nameLast priceChange% changeMarket timeVolumeAvg vol (3-month)Market cap
ABBVAbbVie Inc.134.21-8.51-5.96%16:03 GMT-414.91M5.51M237.27B
BUDAnheuser-Busch InBev SA/NV45.16-0.28-0.62%16:00 GMT-42.65M1.39M79.13B
MOAltria Group, Inc.40.38-0.79-1.92%16:03 GMT-48.57M8.36M74.18B
TAPMolson Coors Brewing Company47.99-0.18-0.37%16:05 GMT-41.35M1.45M10.44B
SMGThe Scotts Miracle-Gro Company42.75-1.37-3.11%16:00 GMT-41.44M624.25k2.35B
WEED.TOCanopy Growth Corporation3.75-0.07-1.83%15:59 GMT-41.35M2.70M1.48B
TLRYTilray Brands, Inc.2.75-0.11-3.85%16:00 GMT-411.86M24.78M1.31B
CGCCanopy Growth Corporation2.73-0.05-1.80%16:00 GMT-44.22M11.84M1.15B
CRONCronos Group Inc.2.82-0.11-3.75%16:00 GMT-41.49M1.91M1.05B
ACBAurora Cannabis Inc.1.22-0.03-2.40%16:00 GMT-44.82M9.74M241.89M
TGODFThe Green Organic Dutchman Holdings Ltd.0.0388-0.00-3.72%15:54 GMT-456.24k353.77k20.82M
CRBPCorbus Pharmaceuticals Holdings, Inc.0.165-0.01-5.61%16:00 GMT-4256.69k951.40k20.66M
CANNGeneral Cannabis Corp0.19+0.00+2.70%15:57 GMT-447.72k49.25k16.11M
NBEVNew Age Beverages Corporation0.0935--16:00 GMT-447.16M10.83M13.73M
MJETFMG Alternative Harvest ETF4.59-0.07-1.50%16:00 GMT-4631.09k1.32M-

    How Far Will AbbVie's Humira Revenue Fall in 2023?

    The world's best-selling drug begins losing patent protections next year. AbbVie's revenue could take years to recover.

  • The Telegraph

    Surging dollar means parity still a threat despite pound revival

    After a rollercoaster ride, the pound has pulled back from the brink of parity with the dollar, defying the doubters who suggested it was all but inevitable at the start of the week.

  • Motley Fool

    Here's Why This Dividend King Is a Buy

    Among the most notable stocks to do so, AbbVie (NYSE: ABBV) is actually trading up 6% on the year. AbbVie is best known as the maker of the top-selling drug in the world, Humira. This stacked lineup of products explains how the drugmaker's net revenue increased 4.5% year over year to $14.6 billion in the second quarter.